BNGO Jan 2025 3.000 put
| Previous Close | 2.6000 |
| Open | 2.6500 |
| Bid | 2.4000 |
| Ask | 2.7000 |
| Strike | 3.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 2.6000 - 2.6500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 33 |
GlobeNewswireBionano Adjourns Special Meeting of Stockholders to October 30, 2024
Special Meeting of Stockholders Adjourned Due to Lack of QuorumSAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on October 2, 2024 (the “Special Meeting”) because a quorum was not present at the time of meeting. Based on preliminary reports as of October 2, 2024, only 22.5% of total shares outstanding as of the record date have submitted their votes, whereas 33.3% of total shares outs
ZacksBears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now
Bionano Genomics (BNGO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
- GlobeNewswire
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference on Monday, September 9th, 2024. Conference & Webcast Details Date:September 9, 2024Time:11:00 a.m. to 11:30 a.m. ETPresenter:Erik Holmlin, PhD, CEO of BionanoWebcast:Link to Register A replay / recording of the session will be available following the
